4 free views remaining today
mitochondrial complex V (ATP synthase) deficiency nuclear type 4B
Description
Mitochondrial Complex V Deficiency Nuclear Type 4B
Mitochondrial complex V deficiency nuclear type 4B, also known as MC5DN4B, is a rare genetic disorder caused by a mutation in the ATP5F1A gene. This condition affects the functioning of mitochondrial complex V, also known as ATP synthase, which is essential for producing energy in cells.
Characteristics and Symptoms
- The onset of symptoms typically occurs at birth.
- Affected individuals may experience horizontal and vertical nystagmus (abnormal eye movements).
- Other possible symptoms include severe neonatal encephalopathy, leading to death within the first weeks of life.
Causes and Genetics
- MC5DN4B is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition.
- The mutation affects the ATP5F1A gene, which codes for a subunit of mitochondrial complex V.
References
- [6] A mitochondrial complex V (ATP synthase) deficiency nuclear type 4 characterized by onset at birth of horizontal and vertical nystagmus, abnormal primitive ...
- [7] A number sign (#) is used with this entry because of evidence that mitochondrial complex V deficiency nuclear type 4B (MC5DN4B) is caused by mutation in the ATP5F1A gene.
- [8] Definition: A mitochondrial complex V (ATP synthase) deficiency nuclear type 4 characterized by onset at birth of horizontal and vertical nystagmus ...
Additional Characteristics
- Mitochondrial complex V deficiency nuclear type 4B
- horizontal and vertical nystagmus
- severe neonatal encephalopathy
Signs and Symptoms
Common Signs and Symptoms
Mitochondrial complex V (ATP synthase) deficiency nuclear type 4B is a rare genetic disorder that affects the production of energy in cells. The signs and symptoms of this condition can vary, but here are some common ones:
- Neonatal-onset hypotonia: Affected individuals may experience low muscle tone from birth [6].
- Lactic acidosis: Elevated levels of lactic acid in the blood can be a sign of mitochondrial dysfunction [6][7].
- Hyperammonemia: High levels of ammonia in the blood can also be associated with this condition [6][7].
- Hypertrophic cardiomyopathy: The heart muscle may become thickened, leading to potential cardiac problems [4][7].
- 3-Methylglutaconic aciduria: This is a type of metabolic disorder that affects the breakdown of certain amino acids [1][6][7].
- Nystagmus: Abnormal eye movements can be present from birth [1][9].
- Seizures: Epileptic seizures can occur due to abnormal electrical activity in the brain [8].
- Resistant seizures: Seizures that are difficult to control may also be a symptom of this condition [5].
Additional Symptoms
Other symptoms associated with mitochondrial complex V (ATP synthase) deficiency nuclear type 4B include:
- Feeding problems
- Slow growth
- Low muscle tone (hypotonia)
- Extreme fatigue (lethargy)
- Developmental delay
It's essential to note that the severity and presentation of symptoms can vary significantly among affected individuals.
References: [1] - Context result 1 [4] - Context result 4 [5] - Context result 5 [6] - Context result 6 [7] - Context result 7 [8] - Context result 8 [9] - Context result 9
Additional Symptoms
- Hyperammonemia
- Seizures
- Slow growth
- Developmental delay
- Feeding problems
- Low muscle tone (hypotonia)
- Hypertrophic cardiomyopathy
- Neonatal-onset hypotonia
- Lactic acidosis
- Extreme fatigue (lethargy)
- 3-Methylglutaconic aciduria
- Resistant seizures
- nystagmus
Diagnostic Tests
Available Diagnostic Tests for Mitochondrial Complex V (ATP Synthase) Deficiency Nuclear Type 4B
Mitochondrial complex V (ATP synthase) deficiency nuclear type 4B can be diagnosed through various genetic and clinical tests. Here are some of the available diagnostic tests:
- Genetic Testing: Genetic testing is a crucial step in diagnosing mitochondrial complex V deficiency nuclear type 4B. This test involves analyzing the DNA to identify mutations in the ATP5F1A gene, which is responsible for this condition [3]. The genetic testing can be done through various methods such as PCR (Polymerase Chain Reaction), sequencing, and microarray analysis.
- Clinical Genetic Test: A clinical genetic test offered by Intergen can also diagnose mitochondrial complex V deficiency nuclear type 4B. This test involves analyzing the genes associated with this condition, including ATP5F1A [3].
- Genetic Testing Registry: The National Institutes of Health (NIH) maintains a registry of genetic tests, which includes information on the genetic testing for mitochondrial complex V deficiency nuclear type 4B [2].
References:
[1] Clinical Genetic Test offered by Intergen for conditions (1): Mitochondrial complex V (ATP synthase) deficiency nuclear type 4B; Testing genes (1): ATP5F1A
[2] Genetic Testing Registry: Mitochondrial complex V (ATP synthase) deficiency nuclear type 4B From the National Institutes of Health
[3] Clinical Genetic Test offered by Intergen for conditions (1): Mitochondrial complex V (ATP synthase) deficiency nuclear type 4B; Testing genes (1): ATP5F1A
Additional Diagnostic Tests
- Genetic Testing
- Clinical Genetic Test
- Genetic Testing Registry
Treatment
Treatment Options for Mitochondrial Complex V Deficiency
Mitochondrial complex V deficiency, also known as ATP synthase deficiency, is a rare genetic disorder that affects the production of energy in cells. While there is no specific treatment for this condition, various drugs have been explored to manage its symptoms.
- Bezafibrate: This fibrate drug has been shown to increase mitochondrial biogenesis and may be beneficial in treating mitochondrial complex V deficiency [6]. However, more research is needed to confirm its effectiveness.
- Nicotinamide riboside (NR): As a precursor of NAD+, NR has been investigated as a potential treatment strategy for various mitochondrial disorders, including complex V deficiency [5].
- Resveratrol: This polyphenol has been found to target the master regulator of mitochondrial biogenesis, PGC-1α, and may have therapeutic benefits in treating mitochondrial complex V deficiency [2].
Current Treatment Approach
While these drugs show promise, the current treatment approach for mitochondrial diseases, including complex V deficiency, is largely supportive. This means that treatment focuses on managing symptoms and improving quality of life rather than addressing the underlying genetic defect [9].
Recommended Medications
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Mitochondrial Complex V Deficiency Nuclear Type 4B: A Comprehensive Overview
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4B, is a rare genetic disorder characterized by the impaired function of the mitochondrial ATP synthase complex. This condition is caused by mutations in the ATP5F1A gene, which encodes for a subunit of the ATP synthase complex.
Key Features and Symptoms
- Encephalopathic Type: Mitochondrial complex V deficiency nuclear type 4B is associated with severe neurological symptoms, including encephalopathy, seizures, and irritability [1].
- Poor Feeding and Failure to Thrive: Infants with this condition often experience poor feeding habits and failure to thrive due to the impaired energy production in their mitochondria [6].
- Horizontal and Vertical Nystagmus: This disorder is also characterized by the presence of horizontal and vertical nystagmus, which are involuntary eye movements [5].
Differential Diagnosis
The differential diagnosis for mitochondrial complex V deficiency nuclear type 4B includes other conditions that present with similar symptoms. These include:
- Mitochondrial Complex V Deficiency Nuclear Type 1: This condition is caused by mutations in different genes and presents with a distinct set of symptoms, including hypertrophic cardiomyopathy [8].
- 3-Methylglutaconic Aciduria: This metabolic disorder can present with similar symptoms to mitochondrial complex V deficiency nuclear type 4B, including encephalopathy and seizures [7].
Clinical Implications
The diagnosis of mitochondrial complex V deficiency nuclear type 4B is crucial for the management and treatment of this condition. Early recognition and intervention can significantly improve the quality of life for individuals with this disorder.
References:
[1] Mitochondrial complex V deficiency, nuclear type 4A (MC5DN4A) is an autosomal dominant metabolic disorder characterized by poor feeding and failure to thrive in infancy [6].
[2] The term differential is used nonrigorously in calculus to refer to an infinitesimal ("infinitely small") change in some varying quantity [10].
[3] Mitochondrial complex V deficiency, nuclear type 1 is a group of defects caused by mutations in nuclear genes, leading to a decrease in ATP synthase complex activity [8].
[4] A differential is a gear train that allows different speeds of rotation for two or more shafts [12].
Additional Differential Diagnoses
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2334
- owl#annotatedSource
- t349681
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0070462
- core#notation
- DOID:0070462
- oboInOwl#hasDbXref
- MIM:615228
- core#exactMatch
- MIM:615228
- oboInOwl#hasExactSynonym
- MC5DN4B
- rdf-schema#label
- mitochondrial complex V (ATP synthase) deficiency nuclear type 4B
- IAO_0000115
- A mitochondrial complex V (ATP synthase) deficiency nuclear type 4 characterized by onset at birth of horizontal and vertical nystagmus, abnormal primitive reflexes, and tonus dysregulation, followed by fatal encephalopathy that has_material_basis_in autosomal recessive inheritance.
- rdf-schema#subClassOf
- t350019
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- RO_0002488
- http://purl.obolibrary.org/obo/HP_0003577
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.